NJ A5719 | 2018-2019 | Regular Session
Note: Carry Foward to future A2830
Note: Carry Foward to future S1650
Note: Carry Foward to future S1650
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on August 23 2019 - 25% progression, died in committee
Action: 2019-08-23 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee
Pending: Assembly Financial Institutions and Insurance Committee
Text: Latest bill text (Introduced) [HTML]
Status: Introduced on August 23 2019 - 25% progression, died in committee
Action: 2019-08-23 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee
Pending: Assembly Financial Institutions and Insurance Committee
Text: Latest bill text (Introduced) [HTML]
Summary
Requires health benefits coverage for buprenorphine and buprenorphine/naloxone for pain treatment without step therapy or fail-first protocols.
Title
Requires health benefits coverage for buprenorphine and buprenorphine/naloxone for pain treatment without step therapy or fail-first protocols.
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2019-08-23 | Assembly | Introduced, Referred to Assembly Financial Institutions and Insurance Committee |
Same As/Similar To
A5719 (Carry Over) 2019-08-23 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee
A5719 (Carry Over) 2019-08-23 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee
S4051 (Same As) 2019-08-23 - Introduced in the Senate, Referred to Senate Commerce Committee
A5719 (Carry Over) 2019-08-23 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee
S4051 (Same As) 2019-08-23 - Introduced in the Senate, Referred to Senate Commerce Committee
Subjects
New Jersey State Sources
| Type | Source |
|---|---|
| Summary | https://www.njleg.state.nj.us/bill-search/2018/A5719 |
| Text | https://pub.njleg.gov/Bills/2018/A9999/5719_I1.HTM |
